NuGenomics
PrivateLast Round
Early Funding
Oct 5, 2023
Total Funding Raised
$500,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
NuGenomics operates in Healthcare & Life Sciences and is based in Bangalore. Its latest recorded funding round was an Early Funding round in October 2023.
NuGenomics is a health-tech company that provides DNA-based genetic testing and personalized wellness plans for weight management, diabetes, and longevity.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics, Sports & Fitness, Personalization
Business Model
B2C
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NuGenomics Comparables
Compare NuGenomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Unlock.fit | 91% | |
| Gena HealthX | 83% | |
| Lifecode Genorex Pvt. Ltd. | 82% |
For institutional investors. Book with your work email.
NuGenomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 5, 2023 | ||||
| Accelerator | Jun 21, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NuGenomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| India Accelerator | Accelerator |
| Inflection Point Ventures | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 297% MoM.
- Aug 1, 2026
Grew 27% QoQ from 11 to 14 employees.
For institutional investors. Book with your work email.
NuGenomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NuGenomics's valuation, stock price, and market status.
Is NuGenomics a public or private company?
NuGenomics is a private company.
What is the current stock price of NuGenomics?
NuGenomics is a private company, so its shares have no public market price. Caplight tracks NuGenomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NuGenomics worth (valuation)?
Valuation information for NuGenomics is not publicly available.
Can I buy NuGenomics stock?
NuGenomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NuGenomics's last funding round?
NuGenomics's most recent funding round was Early Funding on October 5, 2023.
Who are the main investors in NuGenomics?
Key investors in NuGenomics include India Accelerator, Inflection Point Ventures.
Will NuGenomics IPO soon?
No public IPO plans have been announced for NuGenomics.
How can I track NuGenomics secondary market activity?
Caplight tracks bids, offers, and trades in NuGenomics's shares on secondary markets.